An antigen-specific cell therapy for autoimmune disease avoids compromising immunity as a whole.
References
Ellebrecht, C.T. et al. Science 353, 179–184 (2016).
Bach, J.-F. N. Engl. J. Med. 347, 911–920 (2002).
Chatenoud, L. Curr. Opin. Pharmacol. 23, 92–97 (2015).
Hammers, C.M. et al. J. Invest. Dermatol. 135, 742–749 (2015).
Phillips, W.D. & Vincent, A. F1000 Res. 5, 1513 (2016).
Luo, J. et al. J. Neurosci. 29, 13898–13908 (2009).
Ambrosi, A., Sonesson, S.E. & Wahren-Herlenius, M. Exp. Cell Res. 325, 2–9 (2014).
Gleicher, N. & Elkayam, U. Autoimmun. Rev. 12, 1039–1045 (2013).
Skog, A., Lagnefeldt, L., Conner, P., Wahren-Herlenius, M. & Sonesson, S.E. Acta Obstet. Gynecol. Scand. 95, 98–105 (2016).
Serreze, D.V. et al. J. Exp. Med. 184, 2049–2053 (1996).
Pescovitz, M.D. et al. N. Engl. J. Med. 361, 2143–2152 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Chatenoud, L. Precision medicine for autoimmune disease. Nat Biotechnol 34, 930–932 (2016). https://doi.org/10.1038/nbt.3670
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3670
- Springer Nature America, Inc.